Connect with us

Hi, what are you looking for?

Oracle of  Omaha Says – Investing and Stock NewsOracle of  Omaha Says – Investing and Stock News


Diamon Hill CEO names a ‘mispriced’ medical technology stock

Stryker Corporation (NYSE: SYK) is a “mispriced” stock that has potential to offer lucrative returns over the long term, says Heather Brilliant. She’s the Chief Executive of Diamon Hill Capital Management.

Stryker can stand the coming recession

Investors are concerned the looming recession will be a meaningful headwind for the Michigan-headquartered company that offers innovative products and services for elective surgeries.

Brilliant, however, is convinced such fears are a bit overblown. This morning on CNBC’s “Squawk Box”, she said:

I think there’s more concern about how Stryker will be impacted by a recession than their business will actually see. If you look at Stryker’s long-term earnings power, we’re very confident in the business over the long run.

The stock down roughly 20% for the year is attractive in terms of valuation as well.

Why else is she bullish on Stryker stock

In July, Stryker Corporation reported weaker-than-expected results for its fiscal second quarter. Still, Brilliant said:

We think the management team is really strong and has done a great job of investing back into the business and following acquisition strategy when it makes sense. That will show through in the business in the long run.

Partnerships with several players in healthcare including hospitals were among other reasons cited for the constructive outlook. Her view is in line with Wall Street that has a consensus “overweight” rating on the medical technology company.

Stryker Corporation currently has a dividend yield of 1.29%. Other mispriced stocks that Brilliant likes include Google and SunOpta.

The post Diamon Hill CEO names a ‘mispriced’ medical technology stock appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    Tele2 AB today announces a new partnership with security experts EBS to deliver a secure and managed IoT connectivity solution. Tele2 will support EBS...


    Anyone who has filled up the tank of their car this year will be aware of the rollercoaster ride that the price of oil...

    Latest News

    Sen. Patrick Leahy “was not feeling well” on Thursday and was admitted to the hospital overnight for observation, his office said in a statement....

    Latest News

    Joe Manchin is forcing Democrats into a brutal choice: Take a deal now to lower the costs of health care premiums and prescription drugs,...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2023